These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures. Costantino L; Gandolfi F; Bossy-Nobs L; Tosi G; Gurny R; Rivasi F; Vandelli MA; Forni F Biomaterials; 2006 Sep; 27(26):4635-45. PubMed ID: 16716395 [TBL] [Abstract][Full Text] [Related]
3. Surface coverage of didecyl dimethylammonium bromide on poly(lactide-co-glycolide) nanoparticles. Kuo YC; Yu HW Colloids Surf B Biointerfaces; 2011 May; 84(1):253-8. PubMed ID: 21288700 [TBL] [Abstract][Full Text] [Related]
4. Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles. Ghotbi Z; Haddadi A; Hamdy S; Hung RW; Samuel J; Lavasanifar A J Drug Target; 2011 May; 19(4):281-92. PubMed ID: 20590403 [TBL] [Abstract][Full Text] [Related]
5. Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate. Cenni E; Granchi D; Avnet S; Fotia C; Salerno M; Micieli D; Sarpietro MG; Pignatello R; Castelli F; Baldini N Biomaterials; 2008 Apr; 29(10):1400-11. PubMed ID: 18191195 [TBL] [Abstract][Full Text] [Related]
6. Loading efficiency and surface conductance of heparin-modified poly(lactide-co-glycolide) nanoparticles. Kuo YC; Shih KH Colloids Surf B Biointerfaces; 2009 Jul; 71(2):282-7. PubMed ID: 19329287 [TBL] [Abstract][Full Text] [Related]
7. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells. Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655 [TBL] [Abstract][Full Text] [Related]
8. Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution. Tosi G; Vergoni AV; Ruozi B; Bondioli L; Badiali L; Rivasi F; Costantino L; Forni F; Vandelli MA J Control Release; 2010 Jul; 145(1):49-57. PubMed ID: 20338201 [TBL] [Abstract][Full Text] [Related]
9. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles. Chung TW; Wang SS; Tsai WJ Biomaterials; 2008 Jan; 29(2):228-37. PubMed ID: 17953984 [TBL] [Abstract][Full Text] [Related]
10. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery. Katas H; Cevher E; Alpar HO Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405 [TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin. Yin Y; Chen D; Qiao M; Lu Z; Hu H J Control Release; 2006 Dec; 116(3):337-45. PubMed ID: 17097180 [TBL] [Abstract][Full Text] [Related]
12. Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line. Doggui S; Sahni JK; Arseneault M; Dao L; Ramassamy C J Alzheimers Dis; 2012; 30(2):377-92. PubMed ID: 22426019 [TBL] [Abstract][Full Text] [Related]
13. Enhanced angiogenesis of modified porcine small intestinal submucosa with hyaluronic acid-poly(lactide-co-glycolide) nanoparticles: from fabrication to preclinical validation. Mondalek FG; Ashley RA; Roth CC; Kibar Y; Shakir N; Ihnat MA; Fung KM; Grady BP; Kropp BP; Lin HK J Biomed Mater Res A; 2010 Sep; 94(3):712-9. PubMed ID: 20213816 [TBL] [Abstract][Full Text] [Related]
14. A novel technique for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts. Lim HJ; Nam HY; Lee BH; Kim DJ; Ko JY; Park JS Biotechnol Prog; 2007; 23(3):693-7. PubMed ID: 17465527 [TBL] [Abstract][Full Text] [Related]
15. Experimental design and multivariate analysis for optimizing poly(D,L-lactide-co-glycolide) (PLGA) nanoparticle synthesis using molecular micelles. Ganea GM; Sabliov CM; Ishola AO; Fakayode SO; Warner IM J Nanosci Nanotechnol; 2008 Jan; 8(1):280-92. PubMed ID: 18468072 [TBL] [Abstract][Full Text] [Related]
16. Poly(D,L-lactide-co-glycolide acid) nanoparticles for DNA delivery: waiving preparation complexity and increasing efficiency. Gvili K; Benny O; Danino D; Machluf M Biopolymers; 2007 Apr 5-15; 85(5-6):379-91. PubMed ID: 17266128 [TBL] [Abstract][Full Text] [Related]
17. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model. Shah N; Chaudhari K; Dantuluri P; Murthy RS; Das S J Drug Target; 2009 Aug; 17(7):533-42. PubMed ID: 19530913 [TBL] [Abstract][Full Text] [Related]
18. Formulation and characterization of poly (D,L-lactide-co-glycolide) nanoparticle containing vascular endothelial growth factor for gene delivery. Yi F; Wu H; Jia GL J Clin Pharm Ther; 2006 Feb; 31(1):43-8. PubMed ID: 16476119 [TBL] [Abstract][Full Text] [Related]
19. Nanomedical system for nucleic acid drugs created with the biodegradable nanoparticle platform. Yamamoto H; Tahara K; Kawashima Y J Microencapsul; 2012; 29(1):54-62. PubMed ID: 22034956 [TBL] [Abstract][Full Text] [Related]
20. Microporous structure and drug release kinetics of polymeric nanoparticles. Sant S; Thommes M; Hildgen P Langmuir; 2008 Jan; 24(1):280-7. PubMed ID: 18052222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]